C4 Therapeutics, Inc. (CCCC) General and Administrative Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
C4 Therapeutics, Inc. quarterly General and Administrative Expense history and growth rate from 2019 to 2024.
  • C4 Therapeutics, Inc. General and Administrative Expense for the quarter ending March 31, 2024 was $10.3M, a 6% decline year-over-year.
  • C4 Therapeutics, Inc. General and Administrative Expense for the twelve months ending March 31, 2024 was $41.4M, a 1.25% increase year-over-year.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $41.4M $10.3M -$657K -6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $42.1M $10.3M -$198K -1.89% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q4 2023 $42.1M $42.1M -$708K -1.66% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $42.3M $10.5M +$954K +9.96% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $41.3M $10.3M +$411K +4.15% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $40.9M $10.9M -$1.88M -14.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $42.8M $10.5M +$1.71M +19.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q4 2022 $42.8M $42.8M +$9.54M +28.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $41.1M $9.58M +$1.13M +13.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $39.9M $9.9M +$1.28M +14.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $38.7M $12.8M +$5.41M +73% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $33.3M $8.78M +$2.05M +30.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q4 2021 $33.3M $33.3M +$18.1M +119% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $31.2M $8.45M +$5.59M +195% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $25.6M $8.61M +$5.84M +211% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $19.8M $7.41M +$4.57M +161% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $15.2M $6.73M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q4 2020 $15.2M $15.2M +$6.43M +73.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $2.86M +$444K +18.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.77M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $2.84M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $8.77M $8.77M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $2.42M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.